B.Tech(IT) / MCA with 8-10 years experience in ERP, SAP, Hardware and Networking, installation, planning and operations, Industrial automation and support IT infrastructure etc. Ability to work effectively and communicate cross functionally with all levels of management, manage resource and manpower in a large organization
Akums Drugs & Pharmaceuticals Ltd, Haridwar, (India), is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing pharmaceutical companies of India.
AKUMS existing six state-of-the-art manufacturing facilities have huge per day capacity to produce formulations in practically all dosage forms, i.e. Tablets, Capsules, Soft Gels, Dry Syrups, Liquid Orals, Powder in Sachet, Dry & Liquid Injections, Pre-filled Syringes, Large Volume Parenterals (up to 100 ml) and Eye / Ear / Nasal Drops in FORM FILL & SEAL and THREE PIECE Packs.
AKUMS first Plant commissioned in the year 2004 is the State-of-the-Art manufacturing facility producing Tablets, Capsules, Soft – Gelatin Capsules & Dry Syrups with huge PER DAY manufacturing capacity in all sections and has separate blocks for Beta Lactums, Non–Beta Lactums, Cephalosporin & Penicillin.
AKUMS second & third State-of–the-Art world class facilities established in the year 2007 are producing medicines in the form of liquid orals and Jellies (in Plant II) and liquid & dry injections, large volume parenterals, Pre-Filled Syringes and Eye/Ear/Nasal drops in FFS and Three piece pack (in Plant III).
AKUMS fourth world class Facility designed as per USA-FDA norms producing wide range of HORMONAL preparations in Oral (Solid & Liquid) & Injectable forms and fifth plant producing wide range of Skin Ointments & Cosmetic preparations were commissioned in the year 2010.
AKUMS MAXCURE Plant sixth, the state–of-the-art-manufacturing facility was also set up in 2010 and manufacturing Ayurvedic, Nutraceutical & Food supplements for top pharma companies of India.
AKUMS seventh state–of-the-art Manufacturing facility to produce world class Oncology formulations in Oral & Injectable forms is under construction and slated to commence production in the next financial year.